Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Kohl

Showing results (71-80 of 129) with videos related to

Pageof 13
Sort By:
Biochemistry|March 1, 1994
Human immunodeficiency virus type 1 protease inhibitors: evaluation of resistance engendered by amino acid substitutions in the enzyme's substrate binding siteV V Sardana, A J Schlabach, P Graham, et al.
Nature Medicine|August 1, 1995
Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic miceN E Kohl, C A Omer, M W Conner, et al.
Journal of Medicinal Chemistry|September 29, 1995
Pseudodipeptide inhibitors of protein farnesyltransferaseS J deSolms, A A Deana, E A Giuliani, et al.
Journal of Medicinal Chemistry|March 18, 1994
Pseudopeptide inhibitors of Ras farnesyl-protein transferaseS L Graham, S J deSolms, E A Giuliani, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 1994
Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude miceN E Kohl, F R Wilson, S D Mosser, et al.
Science (New York, N.Y.)|June 25, 1993
Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitorN E Kohl, S D Mosser, S J deSolms, et al.
Nature|February 5, 1986
Differential expression of myc family genes during murine developmentK A Zimmerman, G D Yancopoulos, R G Collum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 1999
Treatment with farnesyl-protein transferase inhibitor induces regression of mammary tumors in transforming growth factor (TGF) alpha and TGF alpha/neu transgenic mice by inhibition of mitogenic activity and induction of apoptosisP Nørgaard, B Law, H Joseph, et al.
Cancer Research|March 29, 2013
High-throughput tyrosine kinase activity profiling identifies FAK as a candidate therapeutic target in Ewing sarcomaBrian D Crompton, Anne L Carlton, Aaron R Thorner, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2008
Rapid assembly of diverse and potent allosteric Akt inhibitorsZhicai Wu, Ronald G Robinson, Sheng Fu, et al.
Pageof 13

Showing results (71-80 of 129) with videos related to

Sort By:
Pageof 13
Biochemistry|March 1, 1994
Human immunodeficiency virus type 1 protease inhibitors: evaluation of resistance engendered by amino acid substitutions in the enzyme's substrate binding siteV V Sardana, A J Schlabach, P Graham, et al.
Nature Medicine|August 1, 1995
Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic miceN E Kohl, C A Omer, M W Conner, et al.
Journal of Medicinal Chemistry|September 29, 1995
Pseudodipeptide inhibitors of protein farnesyltransferaseS J deSolms, A A Deana, E A Giuliani, et al.
Journal of Medicinal Chemistry|March 18, 1994
Pseudopeptide inhibitors of Ras farnesyl-protein transferaseS L Graham, S J deSolms, E A Giuliani, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 1994
Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude miceN E Kohl, F R Wilson, S D Mosser, et al.
Science (New York, N.Y.)|June 25, 1993
Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitorN E Kohl, S D Mosser, S J deSolms, et al.
Nature|February 5, 1986
Differential expression of myc family genes during murine developmentK A Zimmerman, G D Yancopoulos, R G Collum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 1999
Treatment with farnesyl-protein transferase inhibitor induces regression of mammary tumors in transforming growth factor (TGF) alpha and TGF alpha/neu transgenic mice by inhibition of mitogenic activity and induction of apoptosisP Nørgaard, B Law, H Joseph, et al.
Cancer Research|March 29, 2013
High-throughput tyrosine kinase activity profiling identifies FAK as a candidate therapeutic target in Ewing sarcomaBrian D Crompton, Anne L Carlton, Aaron R Thorner, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2008
Rapid assembly of diverse and potent allosteric Akt inhibitorsZhicai Wu, Ronald G Robinson, Sheng Fu, et al.
Pageof 13